Y Intercept (Hong Kong) LTD Chroma Dex Corp. Transaction History
Y Intercept (Hong Kong) LTD
- $1.78 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
82Shares Held
16.4MCall Options Held
91.7KPut Options Held
18.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$12.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$11.8 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.97MShares$11.3 Million4.5% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$4.93 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.13MShares$4.3 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $260M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...